This session examines evolving clinical guidelines and treatment innovations. Experts will discuss combination therapies, precision dosing, and adherence optimization. Genomic insights and population data reveal new risk stratification methods. Participants will analyze real-world outcomes of next-generation lipid-lowering agents. It offers a comprehensive look at tackling two key global risk factors.